Synthetic senescent cell antigen
CA 2083150 A1 · Owner: Kay, Marguerite M. B. · Inventors: Marchalonis, John J.; Kay, Marguerite M. B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein is a synthetic senescent cell antigen comprised of purified peptides immunoreactive with antibodies to the naturally occurring antigen. Preferably the synthetic senescent cell, antigen comprises two peptides with the amino acid sequences SKLIKIFQDHPLQKTYN and LFKPPKYHPDVPYVKR respectively. The antigen and , peptides may be used in compositions diagnostic kits, and, methods for detecting or measuring antibodies to senescent cell antigen, studying cellular aging and autoimmune mechanisms separating, anions from a gas or liquid or treating certain diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 24, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 24, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 24, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.